Chief Executive Officer
Anna Sumeray has over 25 years of experience in the life sciences sector with a combination of strategic consultancy, hands-on P&L leadership and deal transaction experience in big pharmaceutical and small biotechnology companies, globally, across Europe and within individual countries.
Anna’s diverse experiences include the build of a successful European biotech business for a US-based company from the ground up and management of Novartis’s oncology businesses in Finland and Germany. She also has significant M&A and licensing experience and was global head of business development and licensing at Novartis Ophthalmics. She has worked in 13 countries and in 4 languages.
Anna has a BSc (Hons) in Biochemistry from the University of Birmingham, UK and an MBA from INSEAD, Fontainebleau, France.
